Exhibit 107

CALCULATION OF FILING FEE TABLES

Form S-8

(Form Type)

Baudax Bio, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               

Security

Type

  

Security

Class

Title

  

Fee

Calculation

Rule

   Amount
Registered(1)		  

Proposed
Maximum

Offering
Price

per Unit

  

Maximum
Aggregate

Offering Price

   Fee Rate  

Amount of
Registration

Fee

               
Equity   Common Stock, par value $0.01   457(h)   17,753(2)   $27.70(3)   $491,758.10(3)   0.0000927   $45.59
               
Equity   Common Stock, par value $0.01   457(c) and 457(h)   5,593(4)   $1.70(5)   $9,508.10(5)   0.0000927   $0.89
         
Total Offering Amounts     $501,266.20     $46.48
         
Total Fee Offsets(6)         —  
         
Net Fee Due               $46.48

 

(1)

Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate number of additional shares of common stock, par value $0.01 (the “Common Stock”) of Baudax Bio, Inc. (the “Registrant”) issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of the Registrant.

(2)

Represents shares of Common Stock that are issuable upon the exercise of non-qualified stock option awards granted between granted to certain employees of the Registrant as an inducement material to their acceptance of employment with the Registrant (the “Inducement Option Awards”) (which amount takes into account the Registrant’s one-for-35 reverse stock split that became effective on February 16, 2022).

(3)

This estimate is made pursuant to Rule 457(h) of the Securities Act. The price shown is based upon the weighted average exercise prices of the Inducement Option Awards (which amount takes into account the Registrant’s one-for-35 reverse stock split that became effective on February 16, 2022).

(4)

This estimate is made pursuant to Rule 457(c) and Rule 457(h) of the Securities Act. The price shown is based upon the average of the high and low prices reported for the common stock on the Nasdaq Capital Market on March 11, 2022.

(5)

Represents shares of Common Stock that are issuable upon the settlement of restricted stock unit awards granted between granted to certain employees of the Registrant as an inducement material to their acceptance of employment with the Registrant (the “Inducement RSUs”) (which amount takes into account the Registrant’s one-for-35 reverse stock split that became effective on February 16, 2022).

(6)

The Registrant does not have any fee offsets.